Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery

被引:96
作者
Karra, Efthimia [1 ]
Yousseif, Ahmed [1 ]
Batterham, Rachel L. [1 ]
机构
[1] UCL, Dept Med, Obes Res Ctr, London WC1E 6JJ, England
关键词
Y GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE-1; PLASMA GHRELIN LEVELS; VERTICAL BANDED GASTROPLASTY; JEJUNOILEAL BYPASS; GUT HORMONE; SLEEVE GASTRECTOMY; BODY-WEIGHT; FOOD-INTAKE; BILIOPANCREATIC DIVERSION;
D O I
10.1016/j.tem.2010.01.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bariatric surgery is the most effective treatment modality for obesity, resulting in durable weight loss and amelioration of obesity-associated comorbidities, particularly type 2 diabetes mellitus (T2DM). Moreover, the metabolic benefits of bariatric surgery occur independently of weight loss. There is increasing evidence that surgically induced alterations in circulating gut hormones mediate these beneficial effects of bariatric surgery. Here, we summarise current knowledge on the effects of different bariatric procedures on circulating gut hormone levels. We also discuss the theories that have been put forward to explain the weight loss and T2DM resolution following bariatric surgery. Understanding the mechanisms mediating these beneficial outcomes of bariatric surgery could result in new nonsurgical treatment strategies for obesity and T2DM.
引用
收藏
页码:337 / 344
页数:8
相关论文
共 74 条
[41]   Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes [J].
Laferrere, Blandine ;
Teixeira, Julio ;
McGinty, James ;
Tran, Hao ;
Egger, Joseph R. ;
Colarusso, Antonia ;
Kovack, Betty ;
Bawa, Baani ;
Koshy, Ninan ;
Lee, Hongchan ;
Yapp, Kimberly ;
Olivan, Blanca .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (07) :2479-2485
[42]   Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters [J].
le Roux, CW ;
Aylwin, SJB ;
Batterham, RL ;
Borg, CM ;
Coyle, F ;
Prasad, V ;
Shurey, S ;
Ghatei, MA ;
Patel, AG ;
Bloom, SR .
ANNALS OF SURGERY, 2006, 243 (01) :108-114
[43]   Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects [J].
Leonetti, F ;
Silecchia, G ;
Iacobellis, G ;
Ribaudo, MC ;
Zappaterreno, A ;
Tiberti, C ;
Iannucci, CV ;
Perrotta, N ;
Bacci, V ;
Basso, MS ;
Basso, N ;
Di Mario, U .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09) :4227-4231
[44]   Long- or short-limb gastric bypass? [J].
MacLean, LD ;
Rhode, BM ;
Nohr, CW .
JOURNAL OF GASTROINTESTINAL SURGERY, 2001, 5 (05) :525-530
[45]  
MASON EE, 1967, SURG CLIN N AM, V47, P1345
[46]   The mechanisms of surgical treatment of type 2 diabetes [J].
Mason, EE .
OBESITY SURGERY, 2005, 15 (04) :459-461
[47]   Diabetes and coronary artery bypass surgery - An examination of perioperative glycemic control and outcomes [J].
McAlister, FA ;
Man, J ;
Bistritz, L ;
Amad, H ;
Tandon, P .
DIABETES CARE, 2003, 26 (05) :1518-1524
[48]   Ultradian ghrelin pulsatility is disrupted in morbidly obese subjects after weight loss induced by malabsorptive bariatric surgery [J].
Mingrone, Geltrude ;
Granato, Luigi ;
Valera-Mora, Elena ;
Iaconelli, Amerigo ;
Calvani, Menotti F. ;
Bracaglia, Roberto ;
Manco, Melania ;
Nanni, Giuseppe ;
Castagneto, Marco .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 83 (05) :1017-1024
[49]   Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects [J].
Morínigo, R ;
Moizé, V ;
Musri, M ;
Lacy, AM ;
Navarro, S ;
Marín, JL ;
Delgado, S ;
Casamitjana, R ;
Vidal, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (05) :1735-1740
[50]   Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects [J].
Näslund, E ;
King, N ;
Mansten, S ;
Adner, N ;
Holst, JJ ;
Gutniak, M ;
Hellström, PM .
BRITISH JOURNAL OF NUTRITION, 2004, 91 (03) :439-446